Costs for mitochondrial medicine will remain high as long as mitochondrial disorders are misdiagnosed

Josef Finsterer (1) , Sinda Zarrouk-Mahjoub (2)

1 Krankenanstalt Rudolfstiftung
2 LR11IPT05 - Laboratoire de Génomique Biomédicale et Oncogénétique - Biomedical Genomics and Oncogenetics Laboratory

Letter to the Editor

Mots clés: Respiratory chain; Costs; Epidemiology; Multiorgan; Mitochondrial

Domaines: Médecine humaine et pathologie

Josef Finsterer, Sinda Zarrouk-Mahjoub. Costs for mitochondrial medicine will remain high as long as mitochondrial disorders are misdiagnosed. Molecular Genetics and Metabolism Reports, 2017, 13, pp.41. ⟨10.1016/j.ymgmr.2017.08.002⟩. ⟨pasteur-02010612⟩